ArticleTobacco control2012
Understanding the vector in order to plan effective tobacco control policies: an analysis of contemporary tobacco industry materials.
Article in Tobacco control, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Tobacco industry pricing strategies in response to excise tax policies: a systematic review.Tobacco control · 2023Pooled it
- A Systematic Review of Tobacco Industry Tactics in Southeast Asia: Lessons for Other Low- And MiddleIncome Regions.International journal of health policy and management · 2021Pooled it
- Impact of tobacco industry pricing and marketing strategy on brand choice, loyalty and cessation in global south countries: a systematic review.International journal of public health · 2020Pooled it
- A comprehensive review: role of smokeless tobacco consumption as a risk factor for diabetes mellitus.Acta diabetologica · 2025Review
- How has the tobacco industry passed tax changes through to consumers in 12 sub-Saharan African countries?Tobacco control · 2025Article
- Expansion of low-price cigarette market and its implications for cigarette tax revenue: Evidence from Bangladesh.Tobacco induced diseases · 2025Article
- The Use of Packaging Descriptors in a Rapidly Growing Market for Capsule Cigarettes: Evidence From Mexico.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024Article
- Tobacco use by sexual and gender minorities: findings from a Brazilian national survey.BMJ open · 2023Article
- Health Taxes on Tobacco, Alcohol, Food and Drinks in Low- and Middle-Income Countries: A Scoping Review of Policy Content, Actors, Process and Context.International journal of health policy and management · 2022Article
- Global market trends of flavor capsule cigarettes and menthol (non-capsule) cigarettes: An ecological analysis using commercial data across 78 countries, 2010-2020.Tobacco induced diseases · 2022Article
- 'It has candy. You need to press on it': young adults' perceptions of flavoured cigarettes in the Philippines.Tobacco control · 2021Article
- A multi-level, multi-jurisdictional strategy: Transnational tobacco companies' attempts to obstruct tobacco packaging restrictions.Global public health · 2019Article
- The US Cigarette Industry: An Economic and Marketing Perspective.Tobacco regulatory science · 2019Article
- Menthol and flavor capsule cigarettes in the Philippines: A comparison of pack design.Tobacco induced diseases · 2019Article
- The Power of Product Innovation: Smokers' Perceptions of Capsule Cigarettes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2018Article
- Anti-tobacco control industry strategies in Turkey.BMC public health · 2018Article
- Integrating economics into the rationale for multisectoral action on obesity.Revista panamericana de salud publica = Pan American journal of public health · 2018Review
- Reassessing policy paradigms: A comparison of the global tobacco and alcohol industries.Global public health · 2018Article
- Zonnic®: a new player in an old field.Substance abuse treatment, prevention, and policy · 2017Review
- The Taiwan Tobacco and Liquor Corporation: To 'join the ranks of global companies'.Global public health · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
This paper builds on tobacco document research by analysing contemporary materials to explore how the global tobacco market has changed, how transnational tobacco companies (TTCs) are responding and the implications for tobacco control. The methods involved analysis of a variety of materials, including tobacco company annual reports, investor relations materials, financial analyst reports, market research reports and data. Once China, where TTCs have little market share, is excluded, global cigarette volumes are already declining. Nevertheless, industry profits continue to increase. This pattern is explained by the pricing power of TTCs-their ability to increase prices faster than volumes fall, a consequence of market failure. Pricing power is now fundamental to the long term future of TTCs. Consequently, and in light of growing regulations, the business model of the TTCs is changing. Product innovation is now a key marketing technique used to drive consumers to buy more expensive (ie, profitable) premium cigarettes. Contrary to established wisdom, high tobacco excise rates, particularly where increases in excise are gradual, can benefit TTCs by enabling price (profit) increases to be disguised. Large intermittent tax increases likely have a greater public health benefit. TTC investments in smokeless tobacco appear designed to eliminate competition between smokeless tobacco and cigarettes, thereby increasing the pricing power of TTCs while enabling them to harness the rhetoric of harm reduction. Monitoring TTCs can inform effective policy development. The value maximising approach of TTCs suggests that a ban on product innovation and more informed tobacco excise policies are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.